We are live on ! Find out more
EI

EAM Investors Portfolio holdings

AUM $866M
1-Year Est. Return 377.14%
This Fund
S&P 500
This Quarter Est. Return
+25.12%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$601M
AUM Growth
+$42.3M
Cap. Flow
-$26.9M
Cap. Flow %
-4.47%
Top 10 Hldgs %
8.35%
Holding
415
New
119
Increased
62
Reduced
89
Closed
133

Top Buys

Rank Stock Value
1
RPD icon
Rapid7
RPD
+$4.22M
2
HRTX icon
Heron Therapeutics
HRTX
+$4.08M
3
EHC icon
Encompass Health
EHC
+$3.91M
4
FICO icon
Fair Isaac
FICO
+$3.84M
5
PGTI
PGT, Inc.
PGTI
+$3.83M

Sector Composition

Rank Sector Weight
1 Healthcare 31.95%
2 Technology 26.81%
3 Industrials 16.38%
4 Consumer Discretionary 8.04%
5 Financials 5.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NKTR icon
1
Nektar Therapeutics
NKTR
$2.39B
$6.81M 1.13%
4,270
+333
+8% +$429K
TRHC
2
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$5.55M 0.92%
143,041
+5,492
+4% +$192K
HRTX icon
3
Heron Therapeutics
HRTX
$86.3M
$4.97M 0.83%
+179,911
New +$4.08M
CUTR
4
DELISTED
Cutera, Inc.
CUTR
$4.92M 0.82%
97,998
+4,100
+4% +$200K
ESPR
5
DELISTED
Esperion Therapeutics
ESPR
$4.75M 0.79%
65,683
+3,511
+6% +$258K
VRNS icon
6
Varonis Systems
VRNS
$5.25B
$4.75M 0.79%
235,266
+12,294
+6% +$228K
CTLP
7
DELISTED
Cantaloupe
CTLP
$4.72M 0.79%
524,142
-107,670
-17% -$962K
INST
8
DELISTED
Instructure, Inc.
INST
$4.68M 0.78%
111,108
-13,081
-11% -$516K
EVBG
9
DELISTED
Everbridge, Inc. Common Stock
EVBG
$4.55M 0.76%
124,226
-6,714
-5% -$225K
RPD icon
10
Rapid7
RPD
$634M
$4.47M 0.74%
+174,796
New +$4.22M
CMTL icon
11
Comtech Telecommunications
CMTL
$51.8M
$4.45M 0.74%
+149,029
New +$3.59M
AXGN icon
12
Axogen
AXGN
$2.1B
$4.38M 0.73%
120,053
-43,128
-26% -$1.32M
VCEL icon
13
Vericel Corp
VCEL
$2.3B
$4.36M 0.73%
438,216
+325,803
+290% +$2.69M
IRTC icon
14
iRhythm Holdings
IRTC
$3.59B
$4.34M 0.72%
68,886
-3,707
-5% -$229K
CBAY
15
DELISTED
Cymabay Therapeutics
CBAY
$4.33M 0.72%
333,737
-100,076
-23% -$1.24M
GRUB
16
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
$4.29M 0.71%
21,141
+1,646
+8% +$291K
XENT
17
DELISTED
Intersect ENT, Inc
XENT
$4.22M 0.7%
107,395
+76,111
+243% +$2.78M
NTNX icon
18
Nutanix
NTNX
$14.9B
$4.21M 0.7%
85,762
+19,487
+29% +$773K
CHGG icon
19
Chegg
CHGG
$108M
$4.18M 0.7%
202,312
+153,321
+313% +$2.9M
SGMO
20
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$4.17M 0.69%
219,415
+141,416
+181% +$3.02M
EHC icon
21
Encompass Health
EHC
$11.2B
$4.15M 0.69%
+91,296
New +$3.91M
PGTI
22
DELISTED
PGT, Inc.
PGTI
$4.12M 0.69%
+220,881
New +$3.83M
PFBC icon
23
Preferred Bank
PFBC
$1.22B
$4.02M 0.67%
62,550
+3,285
+6% +$209K
ZEN
24
DELISTED
ZENDESK INC
ZEN
$4.01M 0.67%
+83,814
New +$3.48M
CARB
25
DELISTED
Carbonite Inc
CARB
$3.96M 0.66%
+137,333
New +$3.68M

Similar funds

EAM Investors's Q1 2018 Portfolio in Review

As of Q1 2018, EAM Investors held 415 positions worth $601M, up 7.6% from $558M the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.

EAM Investors withdrew a net $26.9M in Q1 2018, closing 133 positions and reducing 89 holdings. Its most notable exit was Winnebago Industries, an estimated $5.14M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 23% a quarter earlier, followed by Technology and Industrials.

Against the trend, EAM Investors opened a new position in Rapid7 worth $4.47M.

  • EAM Investors's largest Q1 2018 buy was Rapid7: 174,796 shares worth $4.47M.
  • EAM Investors added most to Palvella Therapeutics in Q1 2018, an estimated $3.22M increase.
  • EAM Investors's biggest Q1 2018 reduction was The Shyft Group, cutting an estimated $3.43M.
  • EAM Investors fully exited Winnebago Industries in Q1 2018, selling an estimated $5.14M.
  • EAM Investors's ten largest holdings make up 8.4% of its $601M portfolio in Q1 2018.
  • EAM Investors opened 119 new positions and closed 133 in Q1 2018.
  • EAM Investors's portfolio value rose 7.6% quarter-over-quarter to $601M.

Based on EAM Investors's 13F filing for Q1 2018, filed 14 May 2018.